Tango Therapeutics, Inc.
NASDAQTango Therapeutics exits its August earnings event with short sellers accelerating rather than retreating, even as the borrow market simultaneously floods with new supply — a divergence that defines the stock's post-print setup. Short interest jumped to 32.9% of the free float on August 11, up 9.3% in a single session and 13.4% on the week. That 33-point reading marks the highest…
TNGX short interest surges 31.7% in one week to 30.8% of float, highest level in recent trading sessions.
Snapshot as of 13 Aug 2026
Tango Therapeutics exits its August earnings event with short sellers accelerating rather than retreating, even as the borrow market simultaneously floods with new supply — a divergence that defines the stock's…
Tango Therapeutics reports today against a backdrop that could not be more divided: short sellers control nearly a third of the free float, yet analysts have been aggressively raising targets since June. Short interest…
Tango Therapeutics heads into its May 15 earnings print having already moved the market — the question now is whether the fundamental story has caught up with the repositioning. The most striking shift in positioning…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TNGX — free to start on ORTEX.
Sign up for free →Open TNGX on ORTEX